Análise do uso inadequado de medicamentos para o tratamento da obesidade e suas implicações clínicas: Uma revisão abrangente
Year: 2026
Type: article
Abstract: This study addresses the risks associated with the inappropriate, indiscriminate use and self-medication of weight-loss drugs and appetite suppressants, such as sibutramine and fenproporex. The central issue lies in the high consumption of these substances, driven by millions of prescriptions and the irregular marketing of compounded products containing mixtures of amphetamines, diuretics, and laxatives, which leads to a significant increase in emergency care visits due to poisoning and metabolic imbalances. Findings from the literature demonstrate that such centrally acting drugs can trigger clinical manifestations ranging from agitation, insomnia, tachycardia, and hypertensive crises to severe complications, such as cardiac arrhythmias, seizures, myocardial infarction, and an approximately 16% increase in the risk of major cardiovascular events. As coping measures, the study highlights the imperative need for stricter dispensing controls and the strengthening of health regulation. It is concluded that a multidisciplinary approach, integrating physicians and pharmacists, combined with health education, regular clinical monitoring, and public awareness campaigns, is essential to ensure efficacy and safety in the treatment of obesity, mitigating the risks associated with the use of these drugs.
Source: Revista fisio&terapia.
DOI: 10.69849/pn8dem72
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W7226014297
